NYSE - Nasdaq Real Time Price USD

Alexandria Real Estate Equities, Inc. (ARE)

Compare
119.57 +1.75 (+1.49%)
At close: August 30 at 4:00 PM EDT
118.87 -0.70 (-0.59%)
After hours: August 30 at 7:35 PM EDT
Loading Chart for ARE
DELL
  • Previous Close 117.82
  • Open 118.78
  • Bid 118.87 x 1300
  • Ask 120.17 x 900
  • Day's Range 117.40 - 119.61
  • 52 Week Range 90.73 - 135.45
  • Volume 1,036,964
  • Avg. Volume 891,992
  • Market Cap (intraday) 20.916B
  • Beta (5Y Monthly) 1.17
  • PE Ratio (TTM) 147.62
  • EPS (TTM) 0.81
  • Earnings Date Oct 21, 2024 - Oct 25, 2024
  • Forward Dividend & Yield 5.20 (4.35%)
  • Ex-Dividend Date Jun 28, 2024
  • 1y Target Est 138.00

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500? company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria has a total market capitalization of $34.4 billion and an asset base in North America of 74.1 million SF as of March 31, 2024, which includes 42.2 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years, 2.5 million RSF of priority anticipated development and redevelopment projects, and 24.1 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

www.are.com

568

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ARE

View More

Performance Overview: ARE

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ARE
3.63%
S&P 500
18.42%

1-Year Return

ARE
6.58%
S&P 500
25.59%

3-Year Return

ARE
35.07%
S&P 500
25.26%

5-Year Return

ARE
6.18%
S&P 500
93.14%

Compare To: ARE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ARE

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    20.92B

  • Enterprise Value

    33.16B

  • Trailing P/E

    147.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.82

  • Price/Book (mrq)

    1.15

  • Enterprise Value/Revenue

    11.03

  • Enterprise Value/EBITDA

    20.70

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.09%

  • Return on Assets (ttm)

    1.35%

  • Return on Equity (ttm)

    1.49%

  • Revenue (ttm)

    3.01B

  • Net Income Avi to Common (ttm)

    139.73M

  • Diluted EPS (ttm)

    0.81

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    561.02M

  • Total Debt/Equity (mrq)

    56.49%

  • Levered Free Cash Flow (ttm)

    1.44B

Research Analysis: ARE

View More

Company Insights: ARE

Research Reports: ARE

View More

People Also Watch